These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 37295474)
41. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients. Sellaturay P; Gurugama P; Harper V; Dymond T; Ewan P; Nasser S Clin Exp Allergy; 2022 Jan; 52(1):12-17. PubMed ID: 34822190 [TBL] [Abstract][Full Text] [Related]
42. Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adults. Shah MM; Layhadi JA; Hourcade DE; Fulton WT; Tan TJ; Dunham D; Chang I; Vel MS; Fernandes A; Lee AS; Liu J; Arunachalam PS; Galli SJ; Boyd SD; Pulendran B; Davis MM; O'Hara R; Park H; Mitchell LM; Akk A; Patterson A; Jerath MR; Monroy JM; Ren Z; Kendall PL; Durham SR; Fedina A; Gibbs BF; Agache I; Chinthrajah S; Sindher SB; Heider A; Akdis CA; Shamji MH; Pham CTN; Nadeau KC Allergy; 2024 Sep; 79(9):2502-2523. PubMed ID: 39033312 [TBL] [Abstract][Full Text] [Related]
43. Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Therapeutic Considerations. Kounis NG; Koniari I; de Gregorio C; Velissaris D; Petalas K; Brinia A; Assimakopoulos SF; Gogos C; Kouni SN; Kounis GN; Calogiuri G; Hung MY Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33807579 [TBL] [Abstract][Full Text] [Related]
44. Successful Desensitization to mRNA COVID-19 Vaccine in a Case Series of Patients With a History of Anaphylaxis to the First Vaccine Dose. AlMuhizi F; Ton-Leclerc S; Fein M; Tsoukas C; Garvey LH; Lee D; Ben-Shoshan M; Isabwe GAC; Copaescu AM Front Allergy; 2022; 3():825164. PubMed ID: 35386647 [TBL] [Abstract][Full Text] [Related]
45. AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy. Ali SB; Perkins G; Ryoo D; Lee M; Tunbridge M; Yuson C; Smith W; Hissaria P; Le TT Allergy Asthma Clin Immunol; 2022 Mar; 18(1):22. PubMed ID: 35272714 [TBL] [Abstract][Full Text] [Related]
46. Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation. Klimek L; Novak N; Cabanillas B; Jutel M; Bousquet J; Akdis CA Allergy; 2021 Nov; 76(11):3307-3313. PubMed ID: 33657648 [TBL] [Abstract][Full Text] [Related]
47. Identifying and Managing Those at Risk for Vaccine-Related Allergy and Anaphylaxis. Stone CA; Garvey LH; Nasser S; Lever C; Triggiani M; Parente R; Phillips EJ J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2008-2022. PubMed ID: 37182566 [TBL] [Abstract][Full Text] [Related]
48. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP). Novembre E; Tosca M; Caffarelli C; Calvani M; Cardinale F; Castagnoli R; Chiappini E; Cravidi C; Del Giudice MM; Duse M; Licari A; Manti S; Martelli A; Ricci G; Pingitore G; Marseglia GL Ital J Pediatr; 2022 May; 48(1):76. PubMed ID: 35578294 [TBL] [Abstract][Full Text] [Related]
50. Updated consensus statements on COVID-19 Vaccine Allergy Safety in Hong Kong. Chiang V; Leung ASY; Au EYL; Ho MHK; Lee TH; Wu AYY; Wong GWK; Li PH Asia Pac Allergy; 2022 Jan; 12(1):e8. PubMed ID: 35174059 [TBL] [Abstract][Full Text] [Related]
51. The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination. Weir C; Sung-In Jang H; Fernando SL Hum Vaccin Immunother; 2023 Dec; 19(1):2182527. PubMed ID: 36912718 [TBL] [Abstract][Full Text] [Related]
52. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines. Mouri M; Imamura M; Suzuki S; Kawasaki T; Ishizaki Y; Sakurai K; Nagafuchi H; Matsumura N; Uchida M; Ando T; Yoshioka K; Ooka S; Sugihara T; Miyoshi H; Mori M; Okada T; Yamaguchi M; Kunishima H; Kato M; Kawahata K Allergol Int; 2022 Oct; 71(4):512-519. PubMed ID: 35718709 [TBL] [Abstract][Full Text] [Related]
53. The adverse reactions to vaccines practice parameter 10 years on-what have we learned? Kelso JM Ann Allergy Asthma Immunol; 2022 Jul; 129(1):35-39. PubMed ID: 35101646 [TBL] [Abstract][Full Text] [Related]
54. Allergic reactions against Covıd-19 vaccines. Ünsal H; Şekerel BE; Şahiner ÜM Turk J Med Sci; 2021 Oct; 51(5):2233-2242. PubMed ID: 34333906 [TBL] [Abstract][Full Text] [Related]
55. Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI). Tuyls S; Van Der Brempt X; Faber M; Gadisseur R; Dezfoulian B; Schrijvers R; Froidure A; Acta Clin Belg; 2022 Jun; 77(3):552-557. PubMed ID: 33792500 [TBL] [Abstract][Full Text] [Related]
56. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines. Sokolowska M; Eiwegger T; Ollert M; Torres MJ; Barber D; Del Giacco S; Jutel M; Nadeau KC; Palomares O; Rabin RL; Riggioni C; Vieths S; Agache I; Shamji MH Allergy; 2021 Jun; 76(6):1629-1639. PubMed ID: 33452689 [TBL] [Abstract][Full Text] [Related]
57. SARS-CoV-2 and allergy - what have we learned after two and a half years? Brockow K; Wang R; Mathes S; Bent R; Faihs V; Eberlein B; Darsow U; Biedermann T Allergol Select; 2023; 7():101-112. PubMed ID: 37056446 [TBL] [Abstract][Full Text] [Related]